SCHEMBL194832

SCHEMBL194832

CCCCCCCC(O)CC

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.58
FFAR1 O14842 2/20 0.56
FFAR4 Q5NUL3 1/20 0.56
LMNA P02545 2/20 0.50
SPHK1 Q9NYA1 2/20 0.50
PSMD14 O00487 2/20 0.48
PLA2G1B P04054 2/20 0.48
MMP2 P08253 2/20 0.48
ATG4B Q9Y4P1 2/20 0.48
HSP90AA1 P07900 1/20 0.48
RAD52 P43351 1/20 0.48
NFKB1 P19838 1/20 0.48
MAPT P10636 1/20 0.48
GMNN O75496 1/20 0.46
POLB P06746 1/20 0.46
CYP2D6 P10635 1/20 0.46
THPO P40225 1/20 0.46
MTOR P42345 1/20 0.46
BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL378964 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL6231411 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL14396082 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL6298504 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL10436370 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL2609783 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL378906 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL10880735 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL22910980 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1
SCHEMBL865533 1.00 GPR84 (0.58) GPR84FFAR1FFAR4LMNASPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1483 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146202-A1 NON-IONIC SURFACTANT COMPOSITION FOR THE PREPARATION OF AQUEOUS EMULSIONS ARKEMA FRANCE (FR) 2026-05-28 US claimed
CN-122005383-A Oily skin care composition and preparation method and application thereof 北京东方淼森生物科技有限公司 2026-05-12 CN claimed
US-20260015454-A1 HIGH PERFORMANCE, AMBIENT CURE POLYURETHANES COMPRISING POLYCAPROLACTONE POLYOLS INGEVITY UK LTD (GB) 2026-01-15 US claimed
WO-2025226482-A1 LIQUID COMPOSITION WITH PERFUME CAPSULES THE PROCTER & GAMBLE COMPANY (US) 2025-10-30 WO claimed
EP-4640801-A1 LIQUID COMPOSITION WITH PERFUME CAPSULES The Procter & Gamble Company (US) 2025-10-29 EP claimed
EP-4640812-A1 LIQUID COMPOSITION WITH PERFUME CAPSULES The Procter & Gamble Company (US) 2025-10-29 EP claimed
US-20250326990-A1 LIQUID COMPOSITION WITH PERFUME CAPSULES PROCTER & GAMBLE (US) 2025-10-23 US claimed
US-20250326989-A1 LIQUID COMPOSITION WITH PERFUME CAPSULES PROCTER & GAMBLE (US) 2025-10-23 US claimed
EP-4605362-A1 NON-IONIC SURFACTANT COMPOSITION FOR THE PREPARATION OF AQUEOUS EMULSIONS ARKEMA FRANCE (FR) 2025-08-27 EP claimed
CN-120082321-A Organic silicon flame-retardant foaming adhesive and preparation process thereof 杭州双头鹰有机硅科技有限公司 2025-06-03 CN claimed
US-5986088-A Process for the preparation of azide derivatives EISAI CO., LTD. (JP) 1999-11-16 US claimed
CN-1218816-A Siloxanes hydrogel polymers JOHNSON & JOHNSON VISION PROD (US) 1999-06-09 CN claimed
EP-0867431-A1 Process for the preparation of azide derivatives Eisai Chemical Co., Ltd. (JP) 1998-09-30 EP claimed
CN-1194264-A Preparing method for azide derivatives EISAI CO LTD (JP) 1998-09-30 CN claimed
EP-0791069-A1 MICROBIAL TRANSFORMATION PROCESS FOR OBTAINING ANTIBIOTIC GE 2270 FACTOR D 2? Biosearch Italia S.p.A. (IT) 1997-08-27 EP claimed
WO-1996014427-A1 MICROBIAL TRANSFORMATION PROCESS FOR OBTAINING ANTIBIOTIC GE 2270 FACTOR D¿2? GRUPPO LEPETIT S.P.A. (IT) 1996-05-17 WO claimed
EP-0122151-B1 PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE MEITO SANGYO KABUSHIKI KAISHA (JP) 1989-02-15 EP claimed
US-4783402-A Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1988-11-08 US claimed
EP-0122151-A2 Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1984-10-17 EP claimed
US-4304943-A Conversion of alkyl and aryl hydroxy compounds producing aldehyde, alcohol and ketone using manganese oxide/nickel oxide/magnesium oxide catalysts PHILLIPS PETROLEUM COMPANY (US) 1981-12-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260146202-A1 NON-IONIC SURFACTANT COMPOSITION FOR THE PREPARATION OF AQUEOUS EMULSIONS DEGS1, EBP, FFAR2 GPR84 1375/4885FFAR1 5/4885FFAR4 33/4885
US-20260015454-A1 HIGH PERFORMANCE, AMBIENT CURE POLYURETHANES COMPRISING POLYCAPROLACTONE POLYOLS PUF60, MORF4L1, C9 GPR84 3469/4885FFAR1 913/4885FFAR4 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.